# US 2022/0259698 A1 · Method for synthesizing zirconium complex

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0259698 A1
- Document ID: US20220259698A1
- Status: Published application
- Kind: A1
- Application number: 17/630,472
- Filed: 2020-06-25
- Published: 2022-08-18
- Earliest claimed: 2019-07-30
- Assignees: JFE Engineering Corporation
- Applicants: Jfe Engineering Corporation
- Inventors: Ryota IMURA
- Web page: https://patentgrep.com/patent/US20220259698A1

## CPC

- C22B 34/14: Obtaining zirconium or hafnium {(treatment or purification of solutions by liquid-liquid extraction, by ion exchange or by adsorption C22B3/00, C01G25/003, C01G27/003)}
- C07D 255/02: not condensed with other rings
- C07D 257/02: not condensed with other rings
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 487/04: Ortho-condensed systems
- C07F 7/003: {without C-Metal linkages}
- A61K 51/0482: {chelates from cyclic ligands, e.g. DOTA}
- C22B: PRODUCTION AND REFINING OF METALS (electrolytic C25); PRETREATMENT OF RAW MATERIALS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A method for synthesizing a zirconium complex includes: mixing a solvent containing an organic substance having a dipole moment of 3.0 D or more, a chelating agent solution in which a chelating agent containing a structure represented by General Formula (1) or General Formula (2) is dissolved, and zirconium dissolved in an acidic solution, to obtain a mixed solution; and setting the mixed solution at a predetermined temperature or more to synthesize a zirconium complex.

## Claims

### Claim at position 1

1-12. (canceled)

### Claim 13

A method for synthesizing a zirconium complex comprising:
mixing
a solvent containing an organic substance having a dipole moment of 3.0 D or more,
a chelating agent solution in which a chelating agent containing a structure represented by General Formula (1) or General Formula (2) is dissolved, and
zirconium dissolved in an acidic solution, to obtain a mixed solution; and
setting the mixed solution at a predetermined temperature or more to synthesize a zirconium complex,
wherein in General Formula (1):
R1, R2, R3, and R4 being each a hydrogen (—H) (in this case, none of R5 to R12 is further connected), a —CH— group, —(CH2)nCH— group, a —N(═O)(CH2)nNCH— group, or a —(CH2)nNC(═O)N—group;
n being an integer of 0 or more;
at least two of R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, and R20 being at least two selected from a carboxylic acid, a primary amide, hydroxamic acid, phosphonic acid, phosphoric acid, sulfonic acid, an alcohol, an amine, phenol, aniline, and an ester, a secondary amide, hydroxamic acid, and a phosphate that are each obtained by adding a substituent to the aforementioned, with the residual substituents being each a hydrogen, an alkyl chain, a tert-butyl blocked carboxylic acid, nitrobenzene, or a substituent-added alkyl chain;
a positron emission tomography (PET) probe or a functional group facilitating bonding of a PET probe being optionally added to a functional group contained in R5 to R20;
the functional group facilitating bonding being a carboxylic acid, a succinimide carboxylate, a tetrafluorophenol carboxylate, an alcohol, an amine, a thiol, isothiocyanate, maleimide, phenol, aniline, benzoic acid, phenyl isothiocyanate, or an alkyne, an azide, dibenzocyclooctyne (DBCO), bicyclononyne (BCN), trans-cyclooctene (TCO), norbornene, tetrazine, or methyltetrazine, which are each a click chemistry reagent; and
R1 to R20 optionally having a structure of the functional group facilitating bonding or a condensed structure of a PET probe and the functional group facilitating bonding, and
wherein in General Formula (2):
R21, R22, and R23 being each a hydrogen (—H) (in this case, none of R24 to R29 is further connected), a —CH— group, —(CH2)nCH— group, a —N(═O)(CH2)nNCH— group, or a —(CH2)nNC(═O)N— group;
n being an integer of 0 or more;
at least two of R24, R25, R26, R27, R28, R29, R30, R31, R32, R33, R34, and R35 being at least two selected from a carboxylic acid, a primary amide, hydroxamic acid, phosphonic acid, phosphoric acid, sulfonic acid, an alcohol, an amine, phenol, aniline, and an ester, a secondary amide, hydroxamic acid, and a phosphate that are each obtained by adding a substituent to the aforementioned, with the residual substituents being each a hydrogen, an alkyl chain, a tert-butyl blocked carboxylic acid, nitrobenzene, or a substituent-added alkyl chain;
a PET probe or a functional group facilitating bonding of a PET probe being optionally added to a functional group contained in R24 to R35;
the functional group facilitating bonding being the following functional group,
a carboxylic acid, a succinimide carboxylate, a tetrafluorophenol carboxylate, an alcohol, an amine, a thiol, isothiocyanate, maleimide, phenol, aniline, benzoic acid, phenyl isothiocyanate, or an alkyne, an azide, DBCO, BCN, TCO, norbornene, tetrazine, or methyltetrazine, which are each a click chemistry reagent; and
R24 to R35 optionally having a structure of the functional group facilitating bonding or a condensed structure of a PET probe and the functional group facilitating bonding.

### Claim 14 (depends on 13)

The method for synthesizing a zirconium complex according to claim 13, wherein the organic substance is at least one substance selected from the group consisting of dimethylsulfoxide (DMSO), N,N-dimethylformamide (DMF), N-methylformamide (NMF), N-methylpyrrolidone (NMP), and urea.

### Claim 15 (depends on 13)

The method for synthesizing a zirconium complex according to claim 13, wherein a concentration of the organic substance is 1 vol % or more and 95 vol % or less.

### Claim 16 (depends on 14)

The method for synthesizing a zirconium complex according to claim 14, wherein a concentration of the organic substance is 1 vol % or more and 95 vol % or less.

### Claim 17 (depends on 13)

The method for synthesizing a zirconium complex according to claim 13, wherein the predetermined temperature is 35° C. or more.

### Claim 18 (depends on 14)

The method for synthesizing a zirconium complex according to claim 14, wherein the predetermined temperature is 35° C. or more.

### Claim 19 (depends on 13)

The method for synthesizing a zirconium complex according to claim 13, wherein the solvent is a solvent purified with a metal removing agent.

### Claim 20 (depends on 14)

The method for synthesizing a zirconium complex according to claim 14, wherein the solvent is a solvent purified with a metal removing agent.

### Claim 21 (depends on 13)

The method for synthesizing a zirconium complex according to claim 13, wherein the acidic solution is hydrochloric acid.

### Claim 22 (depends on 14)

The method for synthesizing a zirconium complex according to claim 14, wherein the acidic solution is hydrochloric acid.

### Claim 23 (depends on 13)

The method for synthesizing a zirconium complex according to claim 13, wherein zirconium dissolved in the acidic solution is mixed into a solution in which the solvent and the chelating agent solution are mixed together immediately before heating at the predetermined temperature or more or after the heating.

### Claim 24 (depends on 14)

The method for synthesizing a zirconium complex according to claim 14, wherein zirconium dissolved in the acidic solution is mixed into a solution in which the solvent and the chelating agent solution are mixed together immediately before heating at the predetermined temperature or more or after the heating.

### Claim 25 (depends on 13)

The method for synthesizing a zirconium complex according to claim 13, wherein at least one of R5 to R20 in General Formula (1) or at least one of R24 to R35 in General Formula (2) bonds a molecular probe or bonds a linker to a molecular probe, via at least one structure selected from the group consisting of Chemical Formulae (16) to (21) and (26).

### Claim 26 (depends on 14)

The method for synthesizing a zirconium complex according to claim 14, wherein at least one of R5 to R20 in General Formula (1) or at least one of R24 to R35 in General Formula (2) bonds a molecular probe or bonds a linker to a molecular probe, via at least one structure selected from the group consisting of Chemical Formulae (16) to (21) and (26).

### Claim 27 (depends on 25)

The method for synthesizing a zirconium complex according to claim 25, wherein the molecular probe is a protein, a peptide, or a low-molecular weight organic compound.

### Claim 28 (depends on 26)

The method for synthesizing a zirconium complex according to claim 26, wherein the molecular probe is a protein, a peptide, or a low-molecular weight organic compound.

### Claim 29 (depends on 27)

The method for synthesizing a zirconium complex according to claim 27, wherein the protein or the peptide includes a natural amino acid, a non-natural amino acid, or both the natural amino acid and the non-natural amino acid and has a linear-chain structure or a cyclic structure.

### Claim 30 (depends on 28)

The method for synthesizing a zirconium complex according to claim 28, wherein the protein or the peptide includes a natural amino acid, a non-natural amino acid, or both the natural amino acid and the non-natural amino acid and has a linear-chain structure or a cyclic structure.

### Claim 31 (depends on 25)

The method for synthesizing a zirconium complex according to claim 25, wherein the linker is polyethylene glycol, an alkyl chain, piperazine, or a complex thereof.

### Claim 32 (depends on 26)

The method for synthesizing a zirconium complex according to claim 26, wherein the linker is polyethylene glycol, an alkyl chain, piperazine, or a complex thereof.

### Claim 33 (depends on 27)

The method for synthesizing a zirconium complex according to claim 27, wherein the linker is polyethylene glycol, an alkyl chain, piperazine, or a complex thereof.

### Claim 34 (depends on 28)

The method for synthesizing a zirconium complex according to claim 28, wherein the linker is polyethylene glycol, an alkyl chain, piperazine, or a complex thereof.

### Claim 35 (depends on 13)

The method for synthesizing a zirconium complex according to claim 13, wherein oxalic acid is added to the acidic solution to adjust a concentration of the oxalic acid to be 10−6 mol/L or more and less than 10−4 mol/L.

### Claim 36 (depends on 14)

The method for synthesizing a zirconium complex according to claim 14, wherein oxalic acid is added to the acidic solution to adjust a concentration of the oxalic acid to be 10−6 mol/L or more and less than 10−4 mol/L.
